Higher incidence of ESRD than mortality in the AASK study.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of the American Society of Nephrology

• Publication date

  2010-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1681/ASN.2010060623PMID 20651162
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rate of ESRD exceeds mortality among African Americans with hypertensive nephrosclerosis.

  2010cited by this paper
• Urinary creatinine excretion, an indirect measure of muscle mass, is an independent predictor of cardiovascular disease and mortality in the general population.

  2009cited by this paper
• White/black racial differences in risk of end-stage renal disease and death.

  2009cited by this paper
• Incidence of end-stage renal disease and death among insured African Americans with chronic kidney disease.

  2009cited by this paper
• Screening for albuminuria identifies individuals at increased renal risk.

  2009cited by this paper
• Long-term outcomes in nondiabetic chronic kidney disease.

  2008cited by this paper
• Race, gender, and socioeconomic disparities in CKD in the United States.

  2008cited by this paper
• Racial differences in mortality among those with CKD.

  2008cited by this paper
• Prevalence of chronic kidney disease in the United States.

  2007cited by this paper
• Age affects outcomes in chronic kidney disease.

  2007cited by this paper
• Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged medicare beneficiaries.

  2007cited by this paper
• Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999.

  2005cited by this paper
• Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

  2004cited by this paper
• Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization.

  2004cited by this paper
• ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: the African American Study of Kidney Disease and Hypertension (AASK) trial.

  2003cited by this paper
• Comparison of cause-specific mortality between respondents and nonrespondents in a population-based prospective study: ten-year follow-up of JPHC Study Cohort I. Japan Public Health Center.

  2002cited by this paper
• Threats to Applicability of Randomised Trials: Exclusions and Selective Participation

  1999cited by this paper

• Association of Race with In-Hospital and Post-Hospitalization Mortality in Patients with Acute Kidney Injury

  2021cites this paper
• A randomized, double-blind, positive-controlled, prospective, dose-response clinical study to evaluate the efficacy and tolerability of an aqueous extract of Terminalia bellerica in lowering uric acid and creatinine levels in chronic kidney disease subjects with hyperuricemia

  2020cites this paper
• Prevalence and Disease Burden of Chronic Kidney Disease.

  2019cites this paper
• Pharmacologic targeting ERK1/2 attenuates the development and progression of hyperuricemic nephropathy in rats

  2017cites this paper
• Uric acid as a target of therapy in CKD.

  2013cites this paper
• EXPERIENCE OF MANAGING ESRD DIETARY MODIFICATIONS

  2012cites this paper
• Early start of dialysis: a critical review.

  2011cites this paper
• Rate of ESRD exceeds mortality among African Americans with hypertensive nephrosclerosis.

  2010cites this paper